Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix is reading this filing.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- National Rollout of PromarkerD and PromarkerEso
- Proteomics International receives $2.0m in R&D tax incentive
- PromarkerEndo Validation and Refinement Complete
- PromarkerD and PromarkerEso Commercial Rollout Update
- Appendix 4E and Annual Report
Later from Proteomics International Laboratories
All Proteomics International Laboratories news releasesFollow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories